Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Dreimer200on Oct 04, 2019 1:52pm

113 Views

Post# 30197477

RE:RE:RE:RE:RE:RE:TFSA contributions

menoalittle:

True enough! My point is, of course, that if I was given faulty information by a CRA agent, then I will plead that the fault was not mine. An extra wrinkle – the first agent I spoke to said that she was not qualified to answer my question. She referred me to someone supposedly more knowledgeable about TFSA matters. For absolute security, one would have to get a written statement from the CRA.

Probably not in the DNA of those with significant amounts of money invested in a 23 cent cancer- treatment stock

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023